C2-0482 sttr phase II

Ended Definitive Contract Awarded Last action

Contract number
HDTRA118C0031
Awardee
Awarding agency
Obligated
$1,271,418

Award facts

Contract value 100% obligated
$1,271,417.59 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Huntsville, AL 35806, USA
Research
STTR Phase II

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 $0
Other Administrative Action P00007 · Infectious disease diagnostics and differentiation of viral VS. Bacterial infections for point of care applications $0
Other Administrative Action P00006 $0
Supplemental Agreement for work within scope P00005 $0
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 · Research & development sttr to provide infectious disease diagnostics and differentiation of viral VS. Bacterial infections for point of care applications. $0
Other Administrative Action P00002 · Develop infectious disease diagnostics and differentiation of viral VS. Bacterial infections for point of care applications $0
Supplemental Agreement for work within scope P00001 · Infectious disease diagnostics and differentiation of viral VS. Bacterial infection $277,180
Other Administrative Action ARZ999 $0
Original award $994,238

About this award

This is a $1,271,417.59 Cost Plus Fixed Fee contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Genecapture, Inc., a for-profit startup company. The contract is for a Small Business Technology Transfer (STTR) Phase II effort focused on developing infectious disease diagnostics and differentiation of viral versus bacterial infections for point-of-care applications. The contract was set aside for small businesses. Genecapture specializes in rapid infectious disease detection solutions using their patented CAPTURE technology, and has received multiple SBIR and STTR contracts from defense agencies to advance their diagnostic capabilities, particularly for military and medical settings.

Quick answers

Who was awarded contract HDTRA118C0031?

HDTRA118C0031 was awarded to Genecapture, Inc. by Defense Threat Reduction Agency (Department of Defense) on March 16, 2018.

How much is contract HDTRA118C0031 worth?

The government has obligated $1,271,418 on HDTRA118C0031.

Was contract HDTRA118C0031 competed?

The extent of competition for HDTRA118C0031 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award